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Of the several immunologic events occurring in nephrotoxic serum nephritis (NTN) 
the autologous phase would  seem to be the most comparable to the often postulated 
autoimmune  antikidney  response  in  human  glomerulonephrifis.  The  autologous 
phase of NTN occurs when the host develops an antibody response to the heterologous 
nephrotoxic gamma globulin  (NTGG) and is characterized by reaction of the host 
antibody with the NTGG bound in the glomemlar capillary walls and by progressive 
glomemlar injury. Kay was the first to point to the role of the host's immune response 
in NTN in rabbits injected with duck antiserum (1, 2). He correlated the develop- 
ment of proteinurla with the  appearance of circulating host antibodies. By abolishing 
the host's immune response with X-irradiation he was able to suppress proteinuria. 
Support for the Kay hypothesis, that circulating antibodies to the nephrotoxin caused 
injury  to  the glomerulus,  was given by the fluorescent  antibody demonstration of 
host gamma globulin  (GG)  in  the  glomeruli  in  NTN  (3).  Further,  Hammer and 
Dixon reported the elimination of the autologous phase of NTN in rats made immuno- 
logically  tolerant at birth to GG from the species supplying the NTGG (4). Fixation 
of complement in the glomeruli  also has been shown  to occur during the autologous 
phase of NTN  (5).  Finally, experiments have been reported in which  passively ad- 
ministered antibodies to the NTGG can be substituted for the host's antibody and 
comparable glomerular injury ensues  (4, 5). 
This  report  presents  quantitative  data  concerning  the  interaction  of  host 
antibody with heterologous NTGG fixed in  the glomeruli and  the functional 
and structural changes associated with this interaction. By inducing and main- 
taining a large host antibody response to the heterologous GG or by repeatedly 
passively administering such antibody, this phase can be produced after injec- 
tion of minute amounts of NTGG which themselves cause no detectable renal 
injury.  Such  circulating  host antibodies  to an exogenous antigen fixed in  the 
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walls of normal glomerular capillaries would presumably act in much the same 
way as would autoantibodies  directed against glomerular antigens.  In addition 
to whatever relevance this model might have to the pathogenesis of some types 
of  human  nephritis,  it  allows  the  fixing  of  a  known  number  of molecules  of 
antigen  (NTGG)  in a  capillary bed of known  area  and the observation  of  the 
consequences of the reaction between these fixed antigens and circulating anti- 
body  to  them.  Such  data  provides  some idea of the  relationship  between  the 
number of antigen-host  antibody  reactions per unit  of capillary filtration sur- 
face and  the  associated pathologic  changes. 
Materials  and Methods 
All experimental animals were Sprague-Dawley rats weighing between  150  to  200  gm. 
Rabbit NTGG prepared as described previously was used in all the experiments (5). Most of 
the experiments were done with NTGG preparations from single rabbits, a few with pools of 
serum  from several animals.  Only slight  quantitative differences  were noted  among  these 
NTGGs and no attempt  will be made to differentiate them.  The amount  of kidney-fixing 
antibody (KFAb) for each preparation of NTGG was determined as previously described (6) 
and averaged 300/zg of KFAb per 10 mg of rabbit NTGG. Three levels of KFAb were em- 
ployed: 380/zg per rat which induces an immediate and continuing proteinuria of 180 to 250 
nag per 24 hours; 180 #g per rat which causes an  immediate and continuing proteinuria of 20 
to 60 mg per 24 hours; and 2 to 45 #g per rat which causes no detectable renal abnormalities. 
Twenty-four-hour collections of urine were made for determination of proteinuria (5). Normal 
protein excretion in rats of the size and weight used varied from 2.7 to 15.6 mg per 24 hours. 
Proteinuria of more than 20 mg per 24 hours was considered abnormal. Injections of 180/zg 
or 380 #g, i.e. 6 or 12 nag of NTGG induced anti-rabbit GG responses in the rats as evidenced 
by the appearance of rat GG in the glomerular capillary loops 1 week after injection. Doses 
of 45 #g or less of KFAb, 1.5 mg or less of rabbit GG, did not induce a detectable anti-rabbit 
GG response. 
Four experiments were done as follows: 
I.  Effect  of Adjuvant Immunization  to Rabbit  GG in Rats with NTN.--Experiments  were 
conducted to determine the effect of a large and continuous anti-rabbit GG response on the 
kidneys of rats receiving the above amounts of KFAb. In order to insure a maintained anti- 
rabbit  GG response,  rats were immunized with normal rabbit  GG (Pentex Inc., Kankakee, 
Illinois Lot 33) in incomplete Freund's adjuvant. The dose varied from 5 to 10 mg per injec- 
tion in 1 ml of adjuvant and was divided among 4 to 6 subcutaneous sites.  In most of the ex- 
periments the rats were immunized at the time of the injection of NTGG and one or more 
times within the next 4 weeks. As control experiments, rats received the same dose of NTGG 
and were either not immunized to rabbit GG in adjuvant or were immunized to bovine serum 
albumin in adjuvant. In the different experiments rats were followed with weekly urinalysis 
for periods of 30 to 100 days after injection of KFAb. 
II.  Effext  of Passive  Immunization  to Rabbit  GG in  Rats with NTN.--Experiments  were 
done to determine the effect of passive administration of rat antiserum against rabbit GG to 
rats receiving 3 to 40 #g of KFAb. The preparation of rat anti-rabbit GG was identical to that 
reported previously (5). Three groups of 4 rats each received a dose of KFAb of 3, 12, or 40 #g 
and 3 weeks later all were injected intravenously with an amount of rat anti-rabbit GG cal- 
culated to bind at equivalence all circulating and fixed NTGG (approximately 150 to 500/zg 
of anti-rabbit GG). Passive administration of antibody was repeated weekly until proteinuria 
developed. The urines of the rats were tested for protein weekly from the injection of KFAb 
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HI.  Half-Disappearance Time of Rat Anti-Rabbit GG from the Kidneys of Nephritic Rats.-- 
Experiments were conducted to determine the half-dlsappearance time of rat anti-rabbit GG 
fixed to rabbit GG in the kidneys. Rats which 14 days previously had received 35 #g of KFAb 
were injected with 1 mg of I13Llabeled rat GG containing 93 #g of anti-rabbit GG antibody. 
The techniques of obtaining and iodinating rat GG have been described  previously (5, 6). 
After injection of the labeled protein, 2 to 4 rats were sacrificed  at different time intervals 
and the amount of radioactivity was determined in the kidney after peffusion in ~ivo with 
NaC1, 0.15 M. The whole kidneys were counted in a sodium iodide crystal scintillation  counter; 
all counts were corrected for background and decay of I18x; the results of each group of rats 
were averaged and expressed  as percentage of injected material fixed to the kidney. As con- 
trols, rats that previously received a similar dose of KFAb were injected with normal rat GG 
labeled with I m  and similarly followed. 
IV.  Antigenicity  of Kidney-Fixed  NTGG.--Expeximents were  conducted  to  determine 
how long the KFAb in the glomexufi would be available as an antigen to react with circulating 
antibodies to rabbit GG. Rats with NTN (induced by 380/zg of KFAb) of varying durations 
were given intravenously 2200/zg of sheep anti-rabbit GG (1 ml sheep serum) and were sacri- 
ficed 24 hours later. Their kidneys were examined for sheep  GG by the fluorescent  antibody 
technique. As controls, rats with NTN received normal sheep serum and were similarly treated. 
The criteria for identification of the patterns of fluorescence in the glomernli were the same 
as reported before (5). 
The kidneys of sacrificed rats were examined by conventional histologic  techniques. Pro- 
lifexative lesions in the glomeruli  were estimated by counting  the number of nuclei per glomeru- 
ins in a 5 micron section counting an average of 30 to 50 glomexull. In one experiment the 
proliferative activity 1 month after NTAb injection was correlated with the incorporation of 
tritium-labeled thymidine into the nuclei of the glomerular cells, i.e. rats received  an intra- 
venous injection of tritiated thymidine (Sehwarz  Laboratories, Inc., Mount Vernon, New 
York, 6.7 ¢/mmole) at a dose of 1/zc per gm of body weight and were sacrificed 2 hours latex; 
the kidneys were then processed  for radioautograph by standard techniques. Kidneys were 
also examined by fluorescent antibody methods using the methodology and antisera previously 
de~ribed; they were  studied for rabbit GG, rat GG, and rat beta-lC (fllC-) globulin (5). 
Antibodies against rabbit GG in the rats receiving NTAb were determined by passive hemag- 
glutination technique  (7).  Precipitating antibodies were  determined by a  modification of 
Heidelbexger's technique (8). Total protein in rat sera were determined by the Folin Ciocalteu 
method  (8).  The percentage of GG in rat serum was determined by paper electrophoresis 
using a spineo vertical (Durrum) cell. In some experiments circulating antibodies to rabbit 
GG in rats receiving NTAb were detected by observing the rate of elimination of a  tracer 
dose  of I13Llabeled normal rabbit GG from  the circulation following  the methodology of 
Dixon (9). 
RESULTS 
I.  Effect of Adjuvant  Immunization  to Rabbit  GG in  Rats witk NTN.--The 
nephritis of rats injected with NTGG  and immunized to rabbit GG in adjuvant 
varied depending on the dose of KFAb given. Rats given 380 ~g of KFAb and 
rabbit  GG in adjuvant developed an acute  and rapidly progressive nephritis 
with  24 hour proteinuria of  180 to  250 mg.  The majority developed a  severe 
nephrofic  syndrome and  died  during the first  2  weeks after  injection.  Rats 
receiving 380  ~g  of  KFAb  alone had  similar proteinurias  but  developed  no 
clinical nephrotic syndrome and suffered  no mortality during the  1st month 
of the disease.  Histologically there was  a  marked difference  between  the  ad- 718  EXPERIMENTAL  GLOMEI~ULONEPHRITIS.  VI 
juvant immunized and unimmunized groups.  From 1 week on unimmunized 
rats presented to a moderate degree all the alterations of NTN, i.e. proliferative 
glomerulonephritis,  glomerular  basement  membrane  thickening,  occasional 
adhesions of the glornerular tuft to Bowman's capsule, and occasional crescent 
formation. The immunized group showed a much more advanced degree of all 
these changes. Glomerular basement membranes were thickened by irregular 
eosinophilic hyaline deposits;  many glomeruli  were  partially  or  completely 
hyalinized and many had crescents. Both groups showed, by fluorescent anti- 
body techniques, rabbit GG, rat GG, and rat fllC-globulin along the walls of 
the glomerular capillaries (membranous pattern). 
Rats injected with 180/zg of KFAb and immunized with rabbit GG in adju- 
vant at time of NTGG injection and 1 month later developed within 1 month 
proteinuria of more than 100 mg per 24 hours. Three of 5 such rats died within 
TABLE I 
Proteinuria  of Rats Receiving 180 tzg of KFAb and Immunized to Rabbit  GG 
Immunize- 
Group  tion 
1  None 
2  Day 30 
3  Day 0, 
day 30 
Average rag urinary protein per 24 hours 
Day 1  Day 8 (4)  Day 15  Day 30  I  Day 46  Day 100 
42.6 (4)*]  53.0  47.5 (4)  42.6  (4)  53.6  (4) 1  51.8  (4) 
68.4 (5)  [  32.6 (5)  56.6  (5)1  44.9  (5) I  127.7 (5)[  120.4 (5) 
71.8 (5)  60.6 (5)  96.0  (5)  117.0  (4)  229.7 (4)  126.0  (2) 
* Figure in parenthesis denotes  number of animals. 
the first 3 months of the disease (Table I, group 3).  Rats receiving 180 Izg of 
KFAb  and immunized with rabbit  GG in  adjuvant only at  1 month after 
NTAb injection (Table I, group 2) had a moderate proteinuria of 30 to 70 mg 
per 24 hours until 2 weeks after immunization with adjuvant when levels of 
proteinuria exceeded 120 mg in 24 hours. There was no mortality among these 
rats during the first 100 days of the disease.  Rats receiving 180/zg of KFAb 
and no further immunization suffered moderate proteinuria  of  40  to 70 mg 
for the whole period of observation of 100 days (Table 1, group 1). The histo- 
pathology of the kidneys 100 days after NTGG injection varied depending on 
the number of immunizations with rabbit GG in adjuvant. Rats not immunized 
showed a mild membranous glomerulonephritis with slight proliferative changes 
in the glomeruli. Rats immunized at the time of NTGG injection and also  1 
month later showed severe glomerular changes with greatly thickened capillary 
walls, proliferation of glomerular cells and many periglomerular crescents. Rats 
immunized only 1 month after NTGG injection had similar changes but to a 
lesser degree. By fluorescent antibody technique, all of the 3 groups showed EMIL  R.  UNANUE  AND  FRANK  J.  DIXON  719 
rabbit GG, rat GG, and rat ~31C-globulin in the walls of the glomerular capil- 
laries. 
Rats injected with 2, 3,  12, 38, or 45 gg of KFAb (amounts corresponding 
to approximately 0.1  to 0.01  ml of a  potent nephrotoxic serum) without im- 
munization to rabbit GG in adjuvant showed no proteinuria, detectable mor- 
phologic changes  or  detectable  circulating antibodies  to  rabbit  GG.  These 
rats  behaved similarly whether they received no adjuvant immunization or 
bovine  serum  albumin  in  adjuvant.  Fluorescent  antibody studies  revealed 
rabbit  GG in the glomerular capillaries in a  fine linear pattern involving all 
the capillary loops only in the groups receiving 38 and 45/zg of KFAb. In all 
groups rat GG and/31C-globulin were detected in weak concentrations in axial 
regions of the glomenfli. Only in the groups receiving 38 and 45/zg of KFAb 
were rat GG and/~lC-globulin detected focally in small amounts in the walls 
of the glomerular capillaries. No histologic abnormalities visible in the light 
microscope were present in any of these groups of rats. 
All rats receiving 12 to 45 gg of KFAb and immunized to rabbit GG in adju- 
vant on the day of NTAb injection and 2 and 4 weeks later developed pro- 
teinuria  during  the  period from 30  to  100 days post KFAb  injection. Pro- 
teinuria varied from 30 to 250 mg per 24 hour period. In different experiments 
sixty to eighty per cent of adjuvant immunized rats receiving 2.0 to 3.5 #g of 
KFAb become proteinuric during a  similar period of observation. Proteinuria 
in these rats varied from 25  to 85 mg per 24 hour period. A  representative 
experiment where rats were followed for 4 weeks is shown in Table II. Circu- 
lating antibodies to rabbit  GG were present in all groups from 8 to  12 days 
after the initial injection of rabbit GG in adjuvant. These were evidenced by 
immune elimination of a  tracer dose of I1a1-labeled normal rabbit  GG or by 
hemagglutination  or  precipitation  methods.  However,  proteinuria  did  not 
develop until several days or weeks after circulating anti-rabbit GG appeared. 
In none of the experiments was there a correlation between the titer of hemag- 
glutinating or precipitating anti-rabbit GG in the serum and the presence or 
degree of proteinuria. The titer of precipitating antibody, 625  to  1875 #g of 
antibody per ml of serum, was calculated to be far in excess  of the amount 
required to bind at equivalence all the persisting antigen (NTGG). The time 
of appearance of proteinuria was related only to the amount of KFAb admin- 
istered as shown in Fig. 1, where rats from different experiments, but receiving 
similar amounts of KFAb, have been grouped. Fluorescent antibody studies 
were done in all groups at different time intervals. As in the rats not immunized 
to rabbit GG in adjuvant, rabbit GG was only detected in the glomeruli of rats 
receiving 38 to 45 gg of KFAb. Rat GG and rat/~lC-globulin were present in 
the glomeruli in a membranous pattern from 8 to 10 days after the injection 
of NTGG  and rabbit  GG in  adjuvant.  Thus,  similar to  the appearance  of 
circulating antibodies, glomerular fixed rat GG and rat/~lC-globulin preceded 720  EXPERIMENTAL  GLOMERULONEPHRITIS.  VI 
the  onset  of proteinuria by days or weeks.  All rats receiving  12  to 45  /~g of 
KFAb showed  rat  GG and  rat fllC-globulin uniformly in all the glomerular 
capillary loops. In the groups receiving 2  to 3.5/zg  of KFAb  the fluorescent 
pattern of rat GG and/~IC was inconstant and showed no correlation with the 
presence of proteinuria. Approximately half of the rats showed these proteins 
in  a  membranous  distribution and  of these  50 per cent had proteinuria;  the 
remaining half showed rat GG and rat/31C-globulin only in focal loops of the 
TABLE II 
Proteinuria of Rats Receiving 2 to 38 Izg of KFAb and Immunized to Rabbit GG* 
Rat No. 
32 
33 
34 
35 
40 
41 
42 
43 
44 
45 
46 
47 
36-39 
Dose of KFAb 
,ug 
38 
38 
38 
38 
12 
12 
12 
12 
2.0 
2,0 
2.0 
2.0 
38 (4) 
Day 1 
11.0 
6.7 
3.4 
1.2 
6.0 
4.3 
1.6 
11.0 
7.6 
4.0 
9.0 
12.0 
5.8 
mg urinary protein per 24 hours 
Day 7 
12.0 
120.0 
11.2 
45.5 
9.3 
14.0 
13.2 
14.6 
12.0 
11.6 
9.0 
2.8 
7.8 
I 
Day 14 
20.0 
86.0 
15.0 
126.0 
45.0 
20.0 
12.0 
27,0 
12.0 
15.0 
12,0 
11,5 
10.2 
I  Day 21 
12.7 
140.0 
9.0 
120.0 
i 
24.0 
]  13.5 
9.0  ] 
14.0 
10.0 
3.6 
10.0 
9.0 
15.3 
Day  30 
I 
i  25.0 
250.0 
16.0 
105,0 
15.0 
55.0 
50.0 
44.0 
55.0 
9.0 
20.0 
42.0 
11.7 
* All rats were immunized  to rabbit GG except numbers 36 to 39 which were controls 
immunized  to bovine serum albumin.  All immunizations were on day of nephrotoxic GG in- 
jection and 14 days later. Results of controls are average of 4 rats. 
glomeruli, and of these 60 per cent had proteinuria. The histologic picture in 
these  groups  of  adjuvant  immunized  rats  varied,  depending  mainly  on  the 
amount of KFAb administered. Rats receiving 38 and 45/~g of KFAb showed 
proliferative changes with a  25 per cent increase in the number of cells in the 
glomeruli;  this  proliferative activity was  correlated  with  the  finding  of  an 
average of 1.3 cells per glomerulus labeled with tritiated thyrnidine in contrast 
to 0.2 labeled cells per glomerulus in normal controls. These rats also showed 
definite basement membrane  thickening.  Rats receiving 2  to  12  #g  of KFAb 
showed no proliferative changes and minimal basement membrane thickening. 
No infiltration of polymorphonuclear leukocytes was noted at any time in the 
glomeruli of any rats receiving 45 gg of KFAb or less. EM/L R. UNANUE  AND  ~RANK  J. DIXON  721 
H.  Effect o/Passive Immunization to Rabbit GG in Rats with NTN.--Rats 
that were passively immunized to rabbit GG 3 weeks after injection of 3,  12, 
or 40 #g of KFAb became proteinuric. The number of injections of rat anti- 
rabbit  GG needed to produce proteinuria was  inversely proportional to  the 
amount of KFAb injected. Three of 4 rats given 40 ~g of KFAb became pro- 
teinuric after two injections of rat  anti-rabbit  GG. The average proteinuria 
1 week after the last injection was 44.4 mg per 24 hours and 3  weeks after 
decreased to an average of 25.0 rag. Three of 4 rats given 12 #g of KFAb be- 
came proteinuric after 4  injections of rat anti-rabbit  GG.  The average pro- 
teinuria 1 week after the last injection was 51.2 nag per 24 hours and 3 weeks 
.o  90-  45.0), 
"~  80-  /  70- 
~"  50- 
40 
30 
20 
. ,oj 
o  7  ,4  21  ~o  5'0 
Days 
,6o 
FIG. 1.  Percentage of rats developing proteinuria when given 2, 12, and 45/~g of KFAb and 
immunized to rabbit GG. On the ordinate is plotted the percentage of proteinuric rats in each 
group. All rats developing proteinufia of more than 20 mg are included. On the absdssa is 
plotted time in days after KFAb injection. 
after it decreased to 40.9 rag. Two of 4 rats given 3 gg of KFAb became pro- 
teinuric after 6  injections of rat anti-rabbit  GG.  The average proteinuria  1 
week after the last injection was 32.5 mg per 24 hours and 3  weeks after it 
decreased to 20.5 rag. 
IlL  ttalf-Disappearance  Time of Rat Anti-Rabbit Ca7 from  the Kidneys  of 
Nephritic  Rats.--As  noted  in  Fig.  2,  Dn-labeled  rat  anti-rabbit  GG in  the 
kidneys of rats which had received 35 #g of KFAb had a  half-disappearance 
time of 14 days. Ii~-labeled normal rat GG was present in the kidneys of rats 
previously injected with 35 #g of KFAb in small concentration and disappeared 
with a  half-time of 5.2 days which is similar to the half-life of rat GG in the 
circulation. The half-disappearance time of rat anti-rabbit GG fixed in the kid- 
ney after correction for the calculated amount of normal rat GG present in the 
vascular system as a contaminant after perfusion, was 17.8 days. 
IV. Antigenicity  of Kidney-Fixed NTGG.--Rats  with  NTN  of 2,  3,  or 4 
months duration when injected with sheep anti-rabbit  GG showed within 24 722  EXPERIMENTAL  GLOM~ERULON'P-PHRITIS.  VI 
hours identical fixation of the sheep antibody in the glomerular capillaries in a 
membranous distribution.  Normal sheep GG injected into NTN rats showed 
in the glomeruli only an axial or mesangial distribution  indicating  a  non-im- 
munologic fixation. Thus, in NTN of 4 months duration  the NTGG was still 
readily available to react with circulating antibodies to it. 
DISCUSSION 
These observations emphasize the  dependence  of renal  injury in NTN on 
two factors;  (a)  the amount of heterologous KFAb in the glomeruli  (6), and 
i.o 
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Days 
Fm 2.  Disappearance of fixed rat anti-rabbit GG from the kidneys of rats which previously 
received 35/zg of KFAb. The ordinate represents the per cent of injected material fixed in 
the kidney. The abscissa represents time after injection of the labeled protein. 
(b) the immune response made by the host to the heterologous NTGG. ANTS 
with much KFAb will induce an immediate renal injury and in sufficient doses 
will also stimulate a  host  antibody response that will further injure  the glo- 
meruli. In such cases renal damage will be continuous and progressive until a 
stage is reached where  the  renal lesion become irreparable.  In this  situation 
adjuvant immunization to the heterologous GG changed a moderate nephritis 
to a  severe, often fatal one.  A  NTS with little KFAb will induce  a  minimal 
immediate renal injury but in sufficient doses will still  stimulate an immune 
response because of the relatively large amounts of heterologous  GG admin- 
istered. In this case the onset of renal damage is delayed until  the host anti- 
body response occurs (4, 5). A potent NTS injected in small enough amounts, 
as is the case in some of the present experiments, will not induce a significant 
immediate renal  injury and will  stimulate  a  small immune response because 
of the small amounts of heterologous GG administered. In this situation neither 
the immediate nor the late aspects of renal injury will be great. However, in EMIL  R.  UNANUE  AND  I~RANK J.  DIXON  723 
these rats increasing and maintaining the host immune response to the GG of 
the species supplying the KFAb enhances the nephritis markedly. When trace 
amounts  of KFAb  were  injected which  themselves produced no  detectable 
injury, adjuvant immunization to the heterologous GG induced a nephritis of 
mild to moderate character. In this latter situation the amount of KFAb fixed 
to the glomeruli appeared to be the determining factor in inducing  disease. 
The circulating antiheterologous GG could produce renal disease only if a suffi- 
cient amount of heterologous GG was fixed in the glomeruli. The lack of cor- 
relation between levels of circulating anti-rabbit GG and proteinuria in adju- 
vant immunized rats receiving small amounts of KFAb might be expected in 
spite of the fact that  the anti-rabbit  GG is causing  the disease because the 
circulating  antibody merely represents an excess above the amount reacting 
with the tissue-fixed antigen. In all these rats more than enough antibody had 
been made to saturate all available tissue-fixed antigen. A parallel to this may 
be seen in a number of the experimental autoimmune diseases in which  levels 
of anti-tissue antibodies do not correlate with extent of tissue damage. In view 
of the observations with anti-rabbit GG this lack of correlation cannot be taken 
as evidence that these antibodies are not the cause of the disease. 
That in rats with NTN, circulating antibodies to rabbit GG will bind to the 
rabbit NTGG fixed in the kidney was evidenced by: (a) the fixation of passively 
administered radioiodinated rat anti-rabbit GG in the kidney and its persistence 
with a half-time of 17.8 days; (b) the fixation of passively administered sheep 
anti-rabbit GG to the glomeruli in a distribution identical to the one shown for 
the antigen (i.e.  the NTGG); and (c) in the experiments with immunized rats, 
the fixation of rat GG in the glomerular capillary walls at the time that anti- 
bodies appear in the circulation. 
In addition to the implications these observations have for NTN, they afford 
some idea of the number of antigenic molecules per unit area of capillary surface 
which are needed to react with antibody in order to produce detectable injury. 
Approximately 2/~g of KFAb in both kidneys of a rat will,  in the presence of 
excess circulating autologous antibody,  lead  to  detectable glomerular injury 
in 60 per cent of rats (i.e.  rats immunized to rabbit  GG). Two/~g of rabbit 
antibody contains 9  )<  10  = molecules  1 which divided among 60,000 glomeruli 
of the 2 kidneys (10)  means  1.3  X  10  s molecules per glomerulus.  The total 
filtration surface of both rat kidneys is 14,000 mm  ~ or 2.3  )<  10  u m#  ~ per glo- 
merulus. Therefore, 2/~g of KFAb per rat means  1 molecule of heterologous 
GG fixed per  1500 m#  ~ of glomerular capillary surface. Assuming  the rabbit 
GG molecule has dimensions of 3 x 25 m/z and cross-sectional areas of 9 to 75 
m/~  2, somewhere between 0.6 to 5 per cent of the capillaries' filtration surface, 
depending upon the orientation of the molecule, would be occupied by 2/zg of 
Calculations based on a molecular weight of rabbit GG of 140,000 and Avogadro's number 
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KFAb. Thus, if antigens occupying 0.6 to 5 per cent of the capillary filtration 
surface are continually exposed to an excess of circulating homologous antibody, 
detectable capillary injury will occur within a matter of days or weeks. 
Continuing immunologic reactions are apparently essential to the production 
of glomerular capillary injury when  only small amounts of capillary-bound 
antigen are involved. Evidence for repeated antigen-antibody reactions is the 
considerable latent period between appearance of host antibody in the circula- 
tion and its fixation in the glomeruli and the appearance of proteinuria. The 
number of antigen molecules apparently determines the duration of the im- 
munologic reactions needed to induce detectable injury as suggested by the 
data in Fig. I where increases in amount of KFAb shorten the interval between 
appearance of circulating and/or fixed host antibody and proteinuria. Further 
evidence for the importance of repeated antigen-antibody reactions in produc- 
ing glomerular injury is the appearance of detectable injury in rats receiving 
small doses of KFAb only after repeated passive administration of anti-rabbit 
GG. Also, the half-disappearance time of rat anti-rabbit GG in the kidneys of 
NTN is  17.8 days while the half-life of NTGG is 52  days (6),  suggesting a 
turnover of circulating host antibody on relatively permanently fixed anti- 
gens.  Finally, the experiments which show a  ready fixation of passively ad- 
ministered anti-rabbit  GG and complement (5)  in the glomeruli weeks after 
injection of NTAb demonstrate the availability of the heterologous GG as a 
fixed antigen as well as the continuity of the antigen-antibody reaction. 
It appears from the present series  of experiments with NTN that antigen- 
antibody reactions  along  the  glomerular  capillary walls  can  lead  to  injury 
under two circumstances. First, the immediate immunologic events which lead 
to acute injury necessitate the involvement of half or more of the filtration 
surface of the glomerular capillaries by antibody (6). Under these circumstances 
the glomerular capillaries and/or nephrons appear to be quite resistant to the 
effects of a sizeable,  acute immunologic insult. Second, the continuing chronic 
immunologic events which can lead to injury necessitate participation of only 
minute amounts of antigen fixed on the glomeruli, involving at most a small per 
cent of the capillary surface. Under both circumstances the end result is similar 
functionally and pathologically though the pathogenetic events  differ in in- 
tensity and duration. This no doubt reflects the limited variety of responses of 
which the glomerulus is capable. Whether different mediators are involved in 
the  two  conditions cannot be  determined  from  these  experiments  but  this 
possibility is now under study. 
CONCLISSIONS 
Nephrotoxic serum nephritis was studied in rats receiving variable amounts 
of kidney-fixing antibody and active or passive immunization to the heterol- 
ogous gamma globulin of the species supplying the nephrotoxic antibody. Rats 
injected with a moderate to a large amount of kidney-fixing antibody (180 to EMIL R.  UNANUE  AND  PRANK  J.  DIXON  725 
380 #g) and immunized to the heterologous gamma globulin developed a more 
severe  nephritis  than  rats  receiving  similar  amounts  of  antibody  without 
further immunization.  Rats  injected with minimal  amounts  of kidney-fixing 
antibody  (2  to 45  #g)  and  immunized  to  the  heterologous gamma  globulin 
developed a moderate nephritis in contrast to rats receiving similar amounts of 
antibody without further immunizations which showed no evidence of renal 
injury. In the rats receiving small doses of kidney-fixing antibody and immuni- 
zation to the heterologous gamma globulin a  lag period existed between the 
appearance of circulating antibody and kidney-fixed host antibodies and the 
appearance of renal injury. This delay apparently reflects the need for a  con- 
tinuing antigen-antibody reaction for some time in order to produce detectable 
injury with  the small amounts of reactants involved. From these data it ap- 
pears that, in the presence of excess circulating antibody, antigens occupying 
at most a few per cent of the glomerular capillary surface can provide an anti- 
gen-antibody interaction which  will  over a  period of time  cause  detectable 
morphological  and  functional  alterations  of  the  glomerulus. 
We are grateful to Dr. Joseph D. Feldman for performing  ultrastructural studies on some 
of the experiments and to Patricia McConahey  for technical assistance. 
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